Foothill Ventures — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Neuexcellneuexcell.comMay 2016
NeuExcell Therapeutics is a clinical-stage gene therapy company developing treatments for neurodegenerative and neurological diseases such as glioma, Alzheimer's disease, and stroke.
BiotechDeep TechState College, US
Gong Chen(CEO)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Cureseq
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.